LNAnteCHIX:LNAP 84 Net Margin % is 2.75% as of Dec. 2025, which is 21% below its 10-year median of 3.48. GuruFocus rates CHIX:LNAP with a GF Score™ of 84/100 and a GF Value™ of €26.47. The stock has 9 warning signs investors should review. Among 668 Healthcare Providers & Services companies, LNAnte ranks worse than 51.2% on this metric.
Net margin is calculated as Net Income divided by its Revenue. LNAnte's Net Income for the
six
months ended in Dec. 2025 was €12.8 Mil. LNAnte's Revenue for the
six
months ended in Dec. 2025 was €466.2 Mil. Therefore, LNAnte's net margin for the quarter that ended in Dec. 2025 was 2.75%.
The historical rank and industry rank for LNAnte's Net Margin % or its related term are showing as below:
CHIX:LNAp'
s Net Margin % Range Over the Past 10 Years
Min: 1.36 Med: 3.48 Max: 4.98
Current: 2.65
CHIX:LNAp's Net Margin % is ranked worse than 51.2% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs CHIX:LNAp: 2.65
LNAnte (CHIX:LNAp) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
LNAnte Net Margin % Related Terms
LNAnte Net Margin % Historical Data
* Premium members only.
The historical data trend for LNAnte's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:LNAP vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, LNAnte's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LNAnte Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LNAnte's Net Margin % distribution charts can be found below:
* The bar in red indicates where LNAnte's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LNAnte (CHIX:LNAP) has a Net Margin % of 2.75% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on LNAnte and its competitors. This is 21% below median its historical median of 3.48. Over the past decade, LNAnte's Net Margin % has ranged from 1.36 to 4.98. According to the industry distribution chart, LNAnte ranks #342 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 51.2%.
Is LNAnte's Net Margin % too high?
LNAnte's current Net Margin % of 2.75% is 21% below median its 10-year median of 3.48. Over the past 10 years, this metric has ranged from a low of 1.36 to a high of 4.98. The Healthcare Providers & Services industry median Net Margin % is 2.89. LNAnte's value of 2.75% is 4.7% below this industry median. Based on the distribution chart, LNAnte ranks #342 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, LNAnte has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does LNAnte's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, LNAnte ranks #342 out of 668 companies for Net Margin %. This places LNAnte in the lower half of its industry. The industry median Net Margin % is 2.89. LNAnte's value of 2.75% is 4.7% below this benchmark. Historically, LNAnte's own Net Margin % has ranged from 1.36 to 4.98 over the past decade. While the company's 10-year median is 3.48 vs. the industry median of 2.89, LNAnte has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LNAnte's current Net Margin % of 2.75% is 4.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on LNAnte and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LNAnte's current Net Margin % is 2.75%, which is 21% below median its own 10-year median of 3.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LNAnte stock overvalued right now?
LNAnte (CHIX:LNAP) has a current Net Margin % of 2.75%. The stock's GF Value™ is €26.47, compared to a current price of €29.60 — trading 11.8% above its estimated fair value. The current Net Margin % is 2.75%, which is 21% below median its 10-year median of 3.48 and 4.7% below the Healthcare Providers & Services industry median of 2.89. LNAnte's overall GF Score™ is 84/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For LNAnte (CHIX:LNAP), the current Net Margin % is 2.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LNAnte (CHIX:LNAP) Overvalued in 2026?
Based on GuruFocus' analysis, LNAnte stock appears to be overvalued.
The current stock price of €29.60 is trading 11.8% above its estimated GF Value™ of €26.47.
Key valuation signals for CHIX:LNAP:
Net Margin %: 2.75% (21% below median its 10-year median of 3.48)
GF Value™: €26.47 vs. price of €29.60 (11.8% above fair value)
Industry Position: 4.7% below the Healthcare Providers & Services median (#342 of 668)
No single metric tells the full story. See the CHIX:LNAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LNA Sante SA is engaged in the management and operation of retirement homes, nursing homes, follow-up care clinics, rehabilitation centers, centers for the disabled and handicapped ageing.
84GF Score
Get the complete analysis for CHIX:LNAP
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:LNAP has been successfully added to your 
